Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Reiche

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Frontiers in Pharmacology|July 1, 2026
Filling the mechanistic and methodological gaps for predicting cytokine release syndrome in humansLaure-Alix Clerbaux, Miriam Alb, Birgit Fogal, et al.
Blood|January 26, 2026
Anti-CD4 Antibody-modulated Transplants for GVHD Prevention in Hematopoietic Cell TransplantationKristina Roth, Dennis Loeffler, Conny Blumert, et al.
Frontiers in Immunology|August 27, 2025
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapiesAlexander Mazein, Oxana Lopata, Kristin Reiche, et al.
Nature Communications|September 21, 2018
Roquin targets mRNAs in a 3'-UTR-specific manner by different modes of regulationKatharina Essig, Nina Kronbeck, Joao C Guimaraes, et al.
Blood Advances|April 7, 2023
Teclistamab impairs detection of BCMA CAR-T cellsBettina Glatte, Kerstin Wenk, Anja Grahnert, et al.
Journal of Hepatology|December 10, 2025
CAR T-cell therapy induces remission in multiorgan IgG4-related disease with hepatobiliary involvementVerena Keitel, Michael C Kreissl, Tobias Goetze, et al.
BMC Cancer|June 22, 2023
Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancerCarolin Schimmelpfennig, Michael Rade, Susanne Füssel, et al.
Nature Communications|January 21, 2018
Binding of NUFIP2 to Roquin promotes recognition and regulation of ICOS mRNANina Rehage, Elena Davydova, Christine Conrad, et al.
Journal of Immunotoxicology|December 10, 2024
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathwaysAlexander Mazein, Muhammad Shoaib, Miriam Alb, et al.
Molecular Medicine (Cambridge, Mass.)|February 2, 2024
A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancerMichael Rade, Markus Kreuz, Angelika Borkowetz, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Pharmacology|July 1, 2026
Filling the mechanistic and methodological gaps for predicting cytokine release syndrome in humansLaure-Alix Clerbaux, Miriam Alb, Birgit Fogal, et al.
Blood|January 26, 2026
Anti-CD4 Antibody-modulated Transplants for GVHD Prevention in Hematopoietic Cell TransplantationKristina Roth, Dennis Loeffler, Conny Blumert, et al.
Frontiers in Immunology|August 27, 2025
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapiesAlexander Mazein, Oxana Lopata, Kristin Reiche, et al.
Nature Communications|September 21, 2018
Roquin targets mRNAs in a 3'-UTR-specific manner by different modes of regulationKatharina Essig, Nina Kronbeck, Joao C Guimaraes, et al.
Blood Advances|April 7, 2023
Teclistamab impairs detection of BCMA CAR-T cellsBettina Glatte, Kerstin Wenk, Anja Grahnert, et al.
Journal of Hepatology|December 10, 2025
CAR T-cell therapy induces remission in multiorgan IgG4-related disease with hepatobiliary involvementVerena Keitel, Michael C Kreissl, Tobias Goetze, et al.
BMC Cancer|June 22, 2023
Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancerCarolin Schimmelpfennig, Michael Rade, Susanne Füssel, et al.
Nature Communications|January 21, 2018
Binding of NUFIP2 to Roquin promotes recognition and regulation of ICOS mRNANina Rehage, Elena Davydova, Christine Conrad, et al.
Journal of Immunotoxicology|December 10, 2024
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathwaysAlexander Mazein, Muhammad Shoaib, Miriam Alb, et al.
Molecular Medicine (Cambridge, Mass.)|February 2, 2024
A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancerMichael Rade, Markus Kreuz, Angelika Borkowetz, et al.
Pageof 8